BHCM
MDT icon

Brevan Howard Capital Management’s Medtronic MDT Stock Holding History

Brevan Howard Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,485
Closed -$215K – 2382
2026
Q1 		$215K Buy
+2,485
New +$238K ﹤0.01% 1854
2024
Q4 		– Sell
-102,791
Closed -$9.25M – 1281
2024
Q3 		$9.25M Buy
+102,791
New +$8.65M 0.06% 73
2024
Q1 		– Sell
-13,522
Closed -$1.11M – 1214
2023
Q4 		$1.11M Buy
+13,522
New +$1.03M 0.01% 209

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Brevan Howard Capital Management's MDT Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,485 shares — an estimated $215K sold.

Brevan Howard Capital Management first reported a position in MDT in Q4 2023 and held it in 3 quarters. The position peaked at $9.25M in Q3 2024. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 2,485 Medtronic shares in Q2 2026, an estimated $215K.
  • Brevan Howard Capital Management first reported a position in Medtronic in Q4 2023 and held it in 3 quarters.
  • Brevan Howard Capital Management's Medtronic position peaked at $9.25M in Q3 2024.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.